| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |